Grand Pharmaceutical Group Limited Stock OTC Markets
Stocks
CGPHF
BMG210A71016
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 17.33B 2.21B 1.9B 1.79B 1.63B 3.05B 210B 3.06B 21.19B 8.2B 107B 8.3B 8.12B 341B | P/E 2026 * |
9.66x | P/E 2027 * | 8.8x |
|---|---|---|---|---|---|
| Enterprise Value | 17.33B 2.21B 1.9B 1.79B 1.63B 3.05B 210B 3.06B 21.19B 8.2B 107B 8.3B 8.12B 341B | EV / Sales 2026 * |
1.34x | EV / Sales 2027 * | 1.23x |
| Free-Float |
34.99% | Yield 2026 * |
4.14% | Yield 2027 * | 4.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 01/06/2021 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 01/09/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 21/03/2005 |
Geng Pei
BRD | Director/Board Member | 66 | 12/05/2011 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 31/12/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.21B | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,002B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 649B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 440B | |
| -0.19% | -0.03% | +29.44% | +37.50% | 346B | |
| -0.81% | -15.63% | +8.56% | +25.47% | 263B | |
| -0.44% | -1.29% | -1.29% | +12.57% | 250B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 213B | |
| -0.64% | -4.09% | -14.59% | -57.70% | 201B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 182B | |
| Average | -1.90% | -2.06% | +23.42% | +43.17% | 393.74B | |
| Weighted average by Cap. | -1.34% | -2.39% | +32.77% | +57.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.95B 1.65B 1.42B 1.34B 1.22B 2.27B 157B 2.29B 15.83B 6.12B 80.01B 6.2B 6.06B 255B | 14.14B 1.8B 1.55B 1.46B 1.33B 2.48B 171B 2.5B 17.28B 6.69B 87.38B 6.77B 6.62B 278B |
| Net income | 1.82B 232M 200M 188M 171M 320M 22B 321M 2.22B 861M 11.25B 871M 852M 35.78B | 2B 255M 219M 206M 188M 351M 24.15B 353M 2.44B 945M 12.35B 957M 936M 39.29B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
- CGPHF Stock
Select your edition
All financial news and data tailored to specific country editions
